Jeff Lucas is named as a lobbyist on federal disclosure filings for 54 clients through Todd Strategy Group. The most recent filing naming them posted in October 2025. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| SOUTHWEST TRANSPLANT ALLIANCE | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| PMI US CORPORATE SERVICES INC. | TODD STRATEGY GROUP | Q3 2025 | Tobacco, Government Issues, Budget/Appropriations |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| NOVARTIS, INC. | TODD STRATEGY GROUP | Q3 2025 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| MERCK & CO., INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| MCKESSON CORPORATION | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| ILLUMINA, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| EMD SERONO INC. | TODD STRATEGY GROUP | Q3 2025 | Pharmacy, Health Issues |
| DH DIAGNOSTICS LLC | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| THE COALITION FOR 21ST CENTURY MEDICINE | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| BRISTOL-MYERS SQUIBB COMPANY | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| BIOGEN, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| BAYER CORPORATION | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| ALNYLAM PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| ALEXION PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q2 2025 | Medicare/Medicaid, Health Issues |
| VANTIVE US HEALTHCARE LLC | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER | TODD STRATEGY GROUP | Q3 2025 | Copyright/Patent/Trademark |
| TRUIST FINANCIAL CORPORATION | TODD STRATEGY GROUP | Q3 2025 | Banking |
| SIEMENS HEALTHINEERS | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| SIDECAR HEALTH | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Pharmacy |
| THE ORTHOFORUM | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| OSRX PHARMACEUTICALS | TODD STRATEGY GROUP | Q2 2025 | Health Issues |
| NOVO NORDISK INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| AMERICAN POLICY VENTURES ACTION | TODD STRATEGY GROUP | Q3 2025 | Economics/Economic Development, Taxation/Internal Revenue Code |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| MEDICAL COUNTERMEASURES COALITION | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| KALDEROS, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| HOSPICE COMPASSUS | TODD STRATEGY GROUP | Q2 2025 | Medicare/Medicaid, Health Issues |
| GLAXOSMITHKLINE LLC | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| GILEAD SCIENCES, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| GENMAB | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| GENENTECH, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Pharmacy |
| FERRING PHARMACEUTICALS INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| EXELIXIS, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark |
| ELI LILLY AND COMPANY | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| BIODESIX, INC. | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| ASTELLAS PHARMA US, INC. | TODD STRATEGY GROUP | Q3 2025 | Pharmacy, Health Issues |
| AMGEN INC. | TODD STRATEGY GROUP | Q3 2025 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| AMERICAN MEDICAL ASSOCIATION | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid, Health Issues |
| AMERICAN COLLEGE OF RADIOLOGY | TODD STRATEGY GROUP | Q3 2025 | Medicare/Medicaid |
| ALKERMES, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| NOMI HEALTH, INC. | TODD STRATEGY GROUP | Q2 2025 | Health Issues |
| FLEXCARE | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| PUERTO RICO DEPARTMENT OF HEALTH | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Budget/Appropriations |
| NETLIST, INC. | TODD STRATEGY GROUP | Q1 2025 | Copyright/Patent/Trademark |
| MUTUAL OF OMAHA | TODD STRATEGY GROUP | Q1 2025 | Insurance |
| MED CLAIMS COMPLIANCE CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| FOX CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Telecommunications, Communications/Broadcasting/Radio/TV, Taxation/Internal Revenue Code |
| PERIMETER SYSTEMS, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| APOLLO GLOBAL MANAGEMENT | TODD STRATEGY GROUP | Q1 2025 | Financial Institutions/Investments/Securities |
| AMERICAN SOCIETY OF NEPHROLOGY | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2025 | 54 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Jeff Lucas. See the Capitol Clarity rankings and method.